Cgp 33304 is a dual leukotriene receptor antagonists and phospholipase A2 inhibiting agent. It may prevent hypoxia secondary to leukotriene induced bronchoconstriction in shock states. CGP 33304 has potential to be an useful therapeutic agent in acute ischemic disorders including traumatic shock. References: Levitt MA, Lefer AM. Efficacy of two leukotriene antagonists in rat traumatic shock. Methods Find Exp Clin Pharmacol. 1987 May;9(5):269-73. PubMed PMID: 3613754.

纯度：≥98%

CAS：111130-14-4